Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,690,072
  • Shares Outstanding, K 71,943
  • Annual Sales, $ 2,893 M
  • Annual Income, $ 492,700 K
  • EBIT $ 588 M
  • EBITDA $ 743 M
  • 60-Month Beta 1.17
  • Price/Sales 6.27
  • Price/Cash Flow 31.01
  • Price/Book 6.59

Options Overview Details

View History
  • Implied Volatility 45.02% (-3.51%)
  • Historical Volatility 28.73%
  • IV Percentile 78%
  • IV Rank 47.35%
  • IV High 68.27% on 04/07/25
  • IV Low 24.12% on 12/08/25
  • Expected Move (DTE 34) 22.93 (8.83%)
  • Put/Call Vol Ratio 0.41
  • Today's Volume 609
  • Volume Avg (30-Day) 108
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 3,614
  • Open Int (30-Day) 3,931
  • Expected Range 236.86 to 282.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.83
  • Number of Estimates 7
  • High Estimate 1.88
  • Low Estimate 1.80
  • Prior Year 1.82
  • Growth Rate Est. (year over year) +0.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
259.39 +0.15%
on 01/16/26
291.38 -10.84%
on 01/06/26
-6.65 (-2.50%)
since 12/16/25
3-Month
253.32 +2.55%
on 11/20/25
322.34 -19.40%
on 10/23/25
-7.40 (-2.77%)
since 10/16/25
52-Week
187.43 +38.61%
on 04/09/25
348.90 -25.54%
on 01/28/25
-77.41 (-22.96%)
since 01/16/25

Most Recent Stories

More News
Earnings Preview: What to Expect From West Pharmaceutical Services' Report

West Pharmaceutical Services will release its fourth-quarter earnings soon, and analysts anticipate a marginal bottom-line growth.

XLV : 155.74 (-0.78%)
$SPX : 6,940.01 (-0.06%)
WST : 259.79 (-7.02%)
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie

EXTON, Pa. , Jan. 12, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the company...

WST : 259.79 (-7.02%)
ABBV : 214.35 (-0.31%)
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States

NORTH CHICAGO, Ill. , Jan. 12, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and West Pharmaceutical Services (NYSE: WST) announced today a definitive agreement for AbbVie to acquire a device manufacturing...

WST : 259.79 (-7.02%)
ABBV : 214.35 (-0.31%)
1 Mid-Cap Stock on Our Watchlist and 2 That Underwhelm

1 Mid-Cap Stock on Our Watchlist and 2 That Underwhelm

UHS : 199.88 (-2.11%)
XPO : 150.41 (-2.60%)
WST : 259.79 (-7.02%)
2 Safe-and-Steady Stocks with Solid Fundamentals and 1 We Question

2 Safe-and-Steady Stocks with Solid Fundamentals and 1 We Question

SRCE : 64.70 (-1.02%)
WST : 259.79 (-7.02%)
PGR : 202.37 (-0.57%)
Biotech’s New Edge: 5 Companies Mastering "How" We Dose

ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. VANCOUVER – Baystreet.ca News Commentary – Pharmaceutical markets are witnessing drug delivery devices surge toward $862.16 billion by 2034 as industry...

MOOD.CN : 0.7700 (+2.67%)
WST : 259.79 (-7.02%)
PODD : 287.70 (+0.42%)
DOSEF : 0.5061 (-10.90%)
LPCN : 11.13 (-1.15%)
DARE : 1.9300 (-1.03%)
West Pharmaceutical Services Stock: Is WST Underperforming the Healthcare Sector?

Although West Pharmaceutical Services stock has underperformed the broader sector, analysts remain bullish about its prospects.

XLV : 155.74 (-0.78%)
TMO : 618.72 (-0.95%)
WST : 259.79 (-7.02%)
1 S&P 500 Stock Worth Your Attention and 2 We Avoid

1 S&P 500 Stock Worth Your Attention and 2 We Avoid

HOLX : 74.98 (-0.05%)
WST : 259.79 (-7.02%)
MCD : 307.43 (-0.39%)
West to Participate in Upcoming Investor Conference

EXTON, Pa. , Dec. 12, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will...

WST : 259.79 (-7.02%)
3 Profitable Stocks We Approach with Caution

3 Profitable Stocks We Approach with Caution

ROCK : 57.00 (-2.16%)
WST : 259.79 (-7.02%)
FND : 76.07 (+0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical...

See More

Key Turning Points

3rd Resistance Point 292.99
2nd Resistance Point 286.19
1st Resistance Point 272.99
Last Price 259.79
1st Support Level 252.99
2nd Support Level 246.19
3rd Support Level 232.99

See More

52-Week High 348.90
Fibonacci 61.8% 287.22
Fibonacci 50% 268.16
Last Price 259.79
Fibonacci 38.2% 249.11
52-Week Low 187.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar